Arax Advisory Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.65M | Buy |
|
|||||
|
2025
Q1 | $2.55M | Buy |
|
|||||
|
2024
Q4 | $1.8M | Buy |
|
|||||
|
2024
Q3 | $1.48M | Buy |
|
|||||
|
2024
Q2 | $1.2M | Buy |
|
|||||
|
2024
Q1 | $1.06M | Sell |
|
|||||
|
2023
Q4 | $1.26M | Sell |
|
|||||
|
2023
Q3 | $1.27M | Buy |
|
|||||
|
2023
Q2 | $831K | Buy |
|
|||||
|
2023
Q1 | $964K | Buy |
|
|||||
|
2022
Q4 | $942K | Sell |
|
|||||
|
2022
Q3 | $832K | Buy |
|
|||||
|
2022
Q2 | $912K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Buy |
|
|||||
|
2021
Q4 | $854K | Buy |
|
|||||
|
2021
Q3 | $666K | Buy |
|
|||||
|
2021
Q2 | $664K | Buy |
|
|||||
|
2020
Q4 | $489K | Buy |
|
|||||
|
2020
Q3 | $390K | Buy |
|
|||||
|
2020
Q2 | $430K | Sell |
|
|||||
|
2020
Q1 | $343K | Sell |
|
|||||
|
2019
Q4 | $404K | Buy |
|
|||||
|
2019
Q3 | $140K | Buy |
|
|||||
|
2019
Q2 | $135K | Buy |
|
|||||
|
2018
Q4 | $176K | Sell |
|
|||||
|
2018
Q3 | $187K | Buy |
|